1. Home
  2. BMRN vs RPM Comparison

BMRN vs RPM Comparison

Compare BMRN & RPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
    SELLHOLDBUYas of 2 days ago
  • RPM
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • BMRN 1996
  • RPM 1947
  • Country
  • BMRN United States
  • RPM United States
  • Employees
  • BMRN N/A
  • RPM N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • RPM Paints/Coatings
  • Sector
  • BMRN Health Care
  • RPM Consumer Discretionary
  • Exchange
  • BMRN Nasdaq
  • RPM Nasdaq
  • Market Cap
  • BMRN 13.7B
  • RPM 16.3B
  • IPO Year
  • BMRN 1999
  • RPM N/A
  • Fundamental
  • Price
  • BMRN $71.44
  • RPM $113.87
  • Analyst Decision
  • BMRN Buy
  • RPM Buy
  • Analyst Count
  • BMRN 22
  • RPM 10
  • Target Price
  • BMRN $94.00
  • RPM $134.40
  • AVG Volume (30 Days)
  • BMRN 1.5M
  • RPM 647.7K
  • Earning Date
  • BMRN 04-23-2025
  • RPM 04-08-2025
  • Dividend Yield
  • BMRN N/A
  • RPM 1.79%
  • EPS Growth
  • BMRN 153.71
  • RPM 24.36
  • EPS
  • BMRN 2.21
  • RPM 5.06
  • Revenue
  • BMRN $2,853,915,000.00
  • RPM $7,345,252,000.00
  • Revenue This Year
  • BMRN $12.23
  • RPM $1.99
  • Revenue Next Year
  • BMRN $9.90
  • RPM $3.45
  • P/E Ratio
  • BMRN $32.37
  • RPM $22.54
  • Revenue Growth
  • BMRN 17.97
  • RPM 0.12
  • 52 Week Low
  • BMRN $60.63
  • RPM $103.69
  • 52 Week High
  • BMRN $94.85
  • RPM $141.79
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 55.89
  • RPM 41.41
  • Support Level
  • BMRN $69.60
  • RPM $115.10
  • Resistance Level
  • BMRN $73.18
  • RPM $117.49
  • Average True Range (ATR)
  • BMRN 1.64
  • RPM 2.15
  • MACD
  • BMRN -0.15
  • RPM 0.13
  • Stochastic Oscillator
  • BMRN 63.45
  • RPM 44.09

Stock Price Comparison Chart: BMRN vs RPM

BMRN
RPM
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025020406080100120140160BMRN VS RPM

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About RPM RPM International Inc.

RPM International Inc manufactures and sells a variety of paints, coatings, and adhesives. The firm organizes itself into four segments based on product type. The construction products group sells coatings, roofing, insulation, and other products to distributors, contractors, and end consumers globally. The performance coatings group produces coatings that are used in construction and industrial applications like floorings and corrosion control. The consumer group sells paint, finishes, and similar products to individual consumers through hardware and craft stores. The specialty products group sells a line of products ranging from niche applications of the other groups to marine finishes, to edible food colorings. The majority of revenue comes from North America.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use